在巴西的SARS-COV-2的各种循环变体中,差异性表位预测
Vanessa de Melo Cavalcanti-Dantas1, Brenda Fernandes2, Pedro Henrique Lopes Ferreira Dantas3
1Department of Virology, Aggeu Magalhães Institute, FIOCRUZ/PE, Brazil.
Computational biology and chemistry
|July 7, 2024
概括
这项研究使用免疫信息学来预测SARS-CoV-2尖端蛋白在七种变体中的表位. 调查结果显示,Delta和Omicron的表位减少,支持更新的COVID-19疫苗提供更好的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 计算生物学 计算生物学
背景情况:
- 严重急性呼吸系统综合征-冠状病毒-2 (SARS-CoV-2) 尖端蛋白驱动宿主细胞感染,并表现出高突变率.
- 斯派克蛋白中的突变可以增强SARS-CoV-2的传染性,感染性和免疫逃避性.
- 了解SARS-CoV-2变种间的表位变异对于疫苗开发至关重要.
研究的目的:
- 使用免疫信息技术,从七种变体中预测和分析SARS-CoV-2尖端蛋白的表位.
- 评估预测T细胞表位的免疫性,干扰素- (IFN-γ) 诱导能力和抗原性.
- 识别线性和结构性B细胞表位,并比较它们在各个变体中的流行率.
主要方法:
- 在七种SARS-CoV-2变种 (武汉,克莱德2,克莱德3,20AEU.1,马,三角形,阿尔法,奥米克朗) 的MHC类I和II表位的in silico预测.
- 对免疫性,IFN-γ诱导和抗原性预测的T细胞表位的评估.
- 预测每个变体的线性和结构B细胞表位.
主要成果:
- 观察到预测的尖端蛋白表位数的减少,特别是在三角形和奥米克朗变种中.
- 各种变体的特定表位特征不同,Omicron在RBD区域的390位缺乏B细胞表位.
- MHC I 和 II 类表位预测有所不同,其中一些表位被保存,另一些则是变异特异的.
结论:
- 观察到的像Omicron这样的变种表位的减少凸显了更新疫苗配方的需要.
- 针对像Omicron这样的主导变异的双对应mRNA疫苗对于强大的免疫反应和预防再感染是必要的.
- 免疫信息学方法对于描述病毒进化和指导针对SARS-CoV-2等快速突变病毒的疫苗设计有价值.
相关概念视频
01:28Diversity of Antigen Receptors
563
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
563
01:05Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K